Johnson & Johnson (JNJ) Cash from Financing Activities (2017 - 2025)
Johnson & Johnson (JNJ) has disclosed Cash from Financing Activities for 17 consecutive years, with -$1.4 billion as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities fell 2.16% to -$1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.5 billion through Dec 2025, down 76.85% year-over-year, with the annual reading at -$5.5 billion for FY2025, 76.85% down from the prior year.
- Cash from Financing Activities hit -$1.4 billion in Q4 2025 for Johnson & Johnson, up from -$8.9 billion in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $10.4 billion in Q1 2025 to a low of -$11.3 billion in Q4 2023.
- Historically, Cash from Financing Activities has averaged -$2.4 billion across 5 years, with a median of -$3.8 billion in 2021.
- Biggest five-year swings in Cash from Financing Activities: plummeted 818.49% in 2021 and later skyrocketed 1808.79% in 2025.
- Year by year, Cash from Financing Activities stood at -$2.2 billion in 2021, then plummeted by 98.69% to -$4.4 billion in 2022, then fell by 6.16% to -$4.7 billion in 2023, then surged by 71.21% to -$1.3 billion in 2024, then decreased by 2.16% to -$1.4 billion in 2025.
- Business Quant data shows Cash from Financing Activities for JNJ at -$1.4 billion in Q4 2025, -$8.9 billion in Q3 2025, and -$5.7 billion in Q2 2025.